Temat: "Carcinoma, Ductal, Breast" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma.
Autorzy:: Cipolla C; Department of Surgical Oncological and Oral Sciences, University of Palermo, Palermo, Italy.; Breast Unit - AOUP Paolo Giaccone Palermo, Palermo, Italy.
Lupo S; Breast Unit - AOUP Paolo Giaccone Palermo, Palermo, Italy.
Grassi N; Department of Surgical Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
Tutino G; Breast Unit - AOUP Paolo Giaccone Palermo, Palermo, Italy.
Greco M; UOC Medical Oncology - AOUP Paolo Giaccone Palermo, Palermo, Italy.
Eleonora D; UOC Medical Oncology - AOUP Paolo Giaccone Palermo, Palermo, Italy.
Gebbia V; Medical Oncology, School of Medicine, University of Enna Kore, Enna, Italy. .; Director Medical Oncology Unit, Cdc Torina, Palermo, Italy. .; Co-coordinator scientific research, Humanitas Istituto Clinico Catanese, Misterbianco, Catania, Italy. .
Valerio MR; Department of Surgical Oncological and Oral Sciences, University of Palermo, Palermo, Italy.; UOC Medical Oncology - AOUP Paolo Giaccone Palermo, Palermo, Italy.; Pokaż więcej
Źródło:: World journal of surgical oncology [World J Surg Oncol] 2024 Apr 17; Vol. 22 (1), pp. 100. Date of Electronic Publication: 2024 Apr 17.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Lobular*/pathology
Carcinoma, Ductal, Breast*/pathology
Breast Neoplasms*/surgery
Breast Neoplasms*/pathology
Sentinel Lymph Node*/surgery
Sentinel Lymph Node*/pathology
Humans ; Female ; Sentinel Lymph Node Biopsy ; Lymphatic Metastasis/pathology ; Retrospective Studies ; Lymph Node Excision ; Lymph Nodes/pathology ; Axilla/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database.
Autorzy:: Balatico M; Department of Pathology and Laboratory Medicine, Huntsman Cancer Institute, University of Utah Health, Salt Lake City.
Ruano AL; Department of Pathology and Laboratory Medicine, Huntsman Cancer Institute, University of Utah Health, Salt Lake City.
Cleary AS; Department of Pathology and Laboratory Medicine, Huntsman Cancer Institute, University of Utah Health, Salt Lake City.
Lomo L; Department of Pathology and Laboratory Medicine, Huntsman Cancer Institute, University of Utah Health, Salt Lake City.
Gulbahce HE; Department of Pathology and Laboratory Medicine, Huntsman Cancer Institute, University of Utah Health, Salt Lake City.; Pokaż więcej
Źródło:: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Mar 01; Vol. 148 (3), pp. 263-264.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Carcinoma, Lobular*/pathology
Carcinoma, Ductal, Breast*/pathology
Male ; Humans

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patients.
Autorzy:: Agaoglu NB; Department of Medical Genetics, Division of Cancer Genetics, Umraniye Training and Research Hospital, Istanbul, Turkey.
Unal B; Department of Medical Genetics, Division of Cancer Genetics, Umraniye Training and Research Hospital, Istanbul, Turkey.; Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Hayes CP; Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Walker M; Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Ng OH; Department of Medical Biology, School of Medicine, Acibadem University, Istanbul, Turkey.
Doganay L; Department of Medical Genetics, Division of Cancer Genetics, Umraniye Training and Research Hospital, Istanbul, Turkey.
Can ND; Department of Molecular Biology Genetics and Biotechnology, Istanbul Technical University, Istanbul, Turkey.
Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Ghazani AA; Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6852. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/epidemiology
Breast Neoplasms*/genetics
Carcinoma, Lobular*
Carcinoma, Ductal, Breast*
Humans ; Female ; Genomics ; Oncogenes

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Tumor microenvironment and immune system preservation in early-stage breast cancer: routes for early recurrence after mastectomy and treatment for lobular and ductal forms of disease.
Autorzy:: Saad HA; Surgical Department, Faculty of Medicine, Zagazig University, Zagazig City, 44661, Egypt. ebramos_.
Baz A; Surgical Department, Alahrar Teaching Hospital, Zagazig University, Zagazig City, 55971, Egypt.
Riad M; Surgical Department, Faculty of Medicine, Zagazig University, Zagazig City, 44661, Egypt.
Eraky ME; Surgical Department, Faculty of Medicine, Zagazig University, Zagazig City, 44661, Egypt.
El-Taher A; Surgical Department, Faculty of Medicine, Zagazig University, Zagazig City, 44661, Egypt.
Farid MI; Surgical Department, Faculty of Medicine, Zagazig University, Zagazig City, 44661, Egypt.
Sharaf K; Surgical Department, Faculty of Medicine, Zagazig University, Zagazig City, 44661, Egypt.
Said HEM; Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig City, 55971, Egypt.
Ibrahim LA; Surgical Department, AlAzhar University, Nasr City, Cairo, 55888, Egypt.; Pokaż więcej
Źródło:: BMC immunology [BMC Immunol] 2024 Jan 25; Vol. 25 (1), pp. 9. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: Breast Neoplasms*/surgery
Carcinoma, Ductal, Breast*/pathology
Carcinoma, Ductal, Breast*/secondary
Carcinoma, Ductal, Breast*/surgery
Carcinoma, Lobular*/pathology
Carcinoma, Lobular*/secondary
Carcinoma, Lobular*/surgery
Humans ; Female ; Mastectomy ; Vimentin/therapeutic use ; Tumor Microenvironment ; Matrix Metalloproteinase 1/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Additional occult cancers identified on staging breast MRI: imaging appearances and pathologic characteristics.
Autorzy:: Nassar L; Department of Diagnostic Radiology, American University of Beirut Medical Center, Beirut, Lebanon.
Nakad S; Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, The University of Chicago, Chicago, Illinois, USA.
Abou Zeid F; Department of Diagnostic Radiology, American University of Beirut Medical Center, Beirut, Lebanon.
Farah Z; Ministry of Public Health-Epidemiological Surveillance Program, Beirut, Lebanon.
Saheb G; Department of Diagnostic Radiology, American University of Beirut Medical Center, Beirut, Lebanon.
Mroueh N; Department of Radiology/Division of Abdominal Imaging, Massachusetts General Hospital, Boston, Massachusetts, USA.
Debs P; The Russel H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Berjawi G; Department of Diagnostic Radiology, American University of Beirut Medical Center, Beirut, Lebanon.; Pokaż więcej
Źródło:: Journal of medical radiation sciences [J Med Radiat Sci] 2023 Dec; Vol. 70 (4), pp. 360-368. Date of Electronic Publication: 2023 Jun 20.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Intraductal, Noninfiltrating*/pathology
Carcinoma, Ductal, Breast*/diagnosis
Carcinoma, Ductal, Breast*/pathology
Breast Neoplasms*/pathology
Humans ; Female ; Retrospective Studies ; Magnetic Resonance Imaging/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis.
Autorzy:: Yang X; Hebei Medical University, Shijiazhuang, China.; Department of Breast Cancer Center, The Fourth Hospital of Hebei Medical University, No. 12, Jian-Kang Road, Shijiazhuang, 050011, China.
Tang T; Department of Breast Cancer Center, The Fourth Hospital of Hebei Medical University, No. 12, Jian-Kang Road, Shijiazhuang, 050011, China.
Zhou T; Department of Breast Cancer Center, The Fourth Hospital of Hebei Medical University, No. 12, Jian-Kang Road, Shijiazhuang, 050011, China. .; Pokaż więcej
Źródło:: World journal of surgical oncology [World J Surg Oncol] 2023 Nov 24; Vol. 21 (1), pp. 364. Date of Electronic Publication: 2023 Nov 24.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*
Carcinoma, Ductal, Breast*/therapy
Humans ; Female ; Retrospective Studies ; Prognosis ; Disease-Free Survival

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers.
Autorzy:: Naeimzadeh Y; School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Ilbeigi S; Walther-Straub Institute, Ludwig-Maximilians-Universität München, Munich, Germany.
Dastsooz H; Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy.; Candiolo, C/o IRCCS, IIGM-Italian Institute for Genomic Medicine, Turin, Italy.; Candiolo Cancer (IT), FPO-IRCCS, Candiolo Cancer Institute, Turin, Italy.
Rafiee Monjezi M; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München, Munich, Germany.
Mansoori Y; Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Tabei SMB; Department of Medical Genetics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.; Pokaż więcej
Źródło:: BioMed research international [Biomed Res Int] 2023 Nov 23; Vol. 2023, pp. 8236853. Date of Electronic Publication: 2023 Nov 23 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Carcinoma, Ductal, Breast*/pathology
Female ; Humans ; Biomarkers, Tumor/genetics ; Breast/pathology ; GTPase-Activating Proteins/genetics ; GTPase-Activating Proteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Evaluating the effectiveness of stain normalization techniques in automated grading of invasive ductal carcinoma histopathological images.
Autorzy:: Voon W; Department of Mechatronics and Biomedical Engineering, Faculty of Engineering and Science, Lee Kong Chian, Universiti Tunku Abdul Rahman, Kampar, Malaysia.
Hum YC; Department of Mechatronics and Biomedical Engineering, Faculty of Engineering and Science, Lee Kong Chian, Universiti Tunku Abdul Rahman, Kampar, Malaysia. .
Tee YK; Department of Mechatronics and Biomedical Engineering, Faculty of Engineering and Science, Lee Kong Chian, Universiti Tunku Abdul Rahman, Kampar, Malaysia.
Yap WS; Department of Electrical and Electronic Engineering, Faculty of Engineering and Science, Lee Kong Chian, Universiti Tunku Abdul Rahman, Kampar, Malaysia.
Nisar H; Department of Electronic Engineering, Faculty of Engineering and Green Technology, Universiti Tunku Abdul Rahman, 31900, Kampar, Malaysia.
Mokayed H; Department of Computer Science, Electrical and Space Engineering, Lulea University of Technology, Lulea, Sweden.
Gupta N; School of Electronics Engineering, Vellore Institute of Technology, Amaravati, AP, India.
Lai KW; Department of Biomedical Engineering, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 22; Vol. 13 (1), pp. 20518. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/pathology
Carcinoma, Ductal*
Carcinoma, Ductal, Breast*/pathology
Humans ; Female ; Breast/pathology ; Neural Networks, Computer ; Staining and Labeling

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Nitrogen isotopic composition as a gauge of tumor cell anabolism-to-catabolism ratio.
Autorzy:: Straub M; Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. .; Max Planck Institute for Chemistry, 55128, Mainz, Germany. .
Auderset A; Max Planck Institute for Chemistry, 55128, Mainz, Germany.; School of Ocean and Earth Science, University of Southampton, Southampton, SO14 3ZH, UK.
de Leval L; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Piazzon N; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Maison D; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Vozenin MC; Radiation Oncology Laboratory/DO/Radio-Oncology/CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Ollivier J; Radiation Oncology Laboratory/DO/Radio-Oncology/CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Petit B; Radiation Oncology Laboratory/DO/Radio-Oncology/CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Sigman DM; Department of Geosciences, Princeton University, Princeton, NJ, 08544, USA.
Martínez-García A; Max Planck Institute for Chemistry, 55128, Mainz, Germany. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 13; Vol. 13 (1), pp. 19796. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Ductal, Breast*/pathology
Carcinoma, Transitional Cell*
Urinary Bladder Neoplasms*
Breast Neoplasms*/pathology
Humans ; Female ; Nitrogen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: A Case Report of HER2 -Amplification in the Breast Without Histological Abnormality.
Autorzy:: Lee M; Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Lee J; Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Lee A; Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.
Kang J; Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Pokaż więcej
Źródło:: International journal of surgical pathology [Int J Surg Pathol] 2023 Aug; Vol. 31 (5), pp. 801-804. Date of Electronic Publication: 2022 Nov 27.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Breast Neoplasms*/diagnosis
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Carcinoma, Intraductal, Noninfiltrating*/diagnosis
Carcinoma, Intraductal, Noninfiltrating*/genetics
Carcinoma, Intraductal, Noninfiltrating*/pathology
Carcinoma, Ductal, Breast*/diagnosis
Carcinoma, Ductal, Breast*/genetics
Carcinoma, Ductal, Breast*/pathology
Female ; Humans ; Adult ; Receptor, ErbB-2/genetics ; Mammography ; Early Detection of Cancer

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma.
Autorzy:: Yu Q; Department of Pathology, The First People's Hospital of Zigong, Zigong, 643099, China.
Wan D; Department of Pathology, The First People's Hospital of Zigong, Zigong, 643099, China.
Fu R; Department of Pathology, The First People's Hospital of Zigong, Zigong, 643099, China.
Li F; Department of Pathology, The First People's Hospital of Zigong, Zigong, 643099, China.
Zhang Y; Department of Pathology, The First People's Hospital of Zigong, Zigong, 643099, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Oct 13; Vol. 13 (1), pp. 17346. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/pathology
Carcinoma, Ductal, Breast*/pathology
Carcinoma, Intraductal, Noninfiltrating*/pathology
Female ; Humans ; Breast/pathology ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Outcome of different radiotherapy strategies after breast conserving surgery in patients with ductal carcinoma in situ (DCIS).
Autorzy:: Wärnberg F; Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
Wadsten C; Department of Surgery, Sundsvall Hospital, Umeå University, Umeå, Sweden.
Karakatsanis A; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Olofsson Bagge R; Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
Holmberg E; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Lindman H; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Sawyer E; Guys Cancer centre, Kings College London, London, UK.
Vicini F; Regional Oncologic Centre, NRG, Oncology, and 21st Century Oncology, Pontiac, MI, USA.
Mann GB; Department of Surgery, The University of Melbourne, Melbourne, Australia.
Karlsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.; Pokaż więcej
Źródło:: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Sep; Vol. 62 (9), pp. 1045-1051. Date of Electronic Publication: 2023 Aug 12.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Intraductal, Noninfiltrating*/surgery
Carcinoma in Situ*/pathology
Radiation Oncology*
Breast Neoplasms*/surgery
Carcinoma, Ductal, Breast*/pathology
Humans ; Female ; Mastectomy, Segmental ; Radiotherapy, Adjuvant ; Neoplasm Recurrence, Local/surgery

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database.
Autorzy:: Wang Y; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Liang Y; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Ye F; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Luo D; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Jin Y; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Li Y; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Zhao W; Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, China.
Chen B; Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, China.
Wang L; Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, China.
Yang Q; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.; Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, China.; Research Institute of Breast Cancer, Shandong University, Jinan, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (18), pp. 18597-18610. Date of Electronic Publication: 2023 Aug 21.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/pathology
Carcinoma, Lobular*/pathology
Carcinoma, Ductal, Breast*/pathology
Bone Neoplasms*
Humans ; Female ; Retrospective Studies ; Prognosis ; Receptor, ErbB-2/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Clinicopathological Features and Prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
Autorzy:: Wang S; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
Li W; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Li S; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Liu X; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
Zhang L; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
Hao C; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
Meng W; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
Zhao W; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
Tong Z; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Pokaż więcej
Źródło:: International journal of surgical pathology [Int J Surg Pathol] 2023 Sep; Vol. 31 (6), pp. 1075-1084. Date of Electronic Publication: 2023 Feb 19.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Carcinoma, Lobular*/pathology
Carcinoma, Ductal, Breast*/pathology
Gastrointestinal Neoplasms*
Humans ; Female ; Retrospective Studies ; Prognosis ; Endoscopy, Gastrointestinal

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Effectiveness of Carbon Localization for Invasive Breast Cancer: An Institutional Experience.
Autorzy:: El-Helou E; Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Eddy C; Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Picchia S; Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Van de Merckt C; Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Radermeker M; Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Moreau M; Data Centre and Statistic Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
De Neubourg F; Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Larsimont D; Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Veys I; Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Pop CF; Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Pokaż więcej
Źródło:: The breast journal [Breast J] 2023 Jul 18; Vol. 2023, pp. 4082501. Date of Electronic Publication: 2023 Jul 18 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/surgery
Breast Neoplasms*/pathology
Carcinoma, Ductal, Breast*/diagnostic imaging
Carcinoma, Ductal, Breast*/surgery
Carcinoma, Ductal, Breast*/pathology
Humans ; Female ; Retrospective Studies ; Cross-Sectional Studies ; Breast/pathology ; Mastectomy, Segmental/methods ; Reoperation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer.
Autorzy:: Ye Q; West Virginia University Cancer Institute/Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506, USA.
Wang J; West Virginia University Cancer Institute/Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506, USA.
Ducatman B; Department of Pathology, West Virginia University, Morgantown, WV 26506, USA.
Raese RA; West Virginia University Cancer Institute/Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506, USA.
Rogers JL; West Virginia University Cancer Institute/Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506, USA.
Wan YW; West Virginia University Cancer Institute/Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506, USA.
Dong C; West Virginia University Cancer Institute/Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506, USA.
Padden L; West Virginia University Cancer Institute/Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506, USA.
Pugacheva EN; West Virginia University Cancer Institute/Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506, USA.; Department of Biochemistry and Molecular Medicine, School of Medicine, West Virginia University, Morgantown, WV 26506, USA.; Department of Radiation Oncology, School of Medicine, West Virginia University, Morgantown, WV 26506, USA.
Qian Y; Pathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.
Guo NL; West Virginia University Cancer Institute/Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506, USA.; Department of Occupational and Environmental Health Sciences, School of Public Health, West Virginia University, Morgantown, WV 26506, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jun 23; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 23.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/diagnosis
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Carcinoma, Ductal, Breast*/diagnosis
Carcinoma, Ductal, Breast*/drug therapy
Carcinoma, Ductal, Breast*/genetics
Carcinoma, Intraductal, Noninfiltrating*/pathology
Humans ; Female ; Patient Selection ; Hyperplasia/pathology ; Breast/metabolism ; Drug Development ; Proto-Oncogene Proteins ; Homeodomain Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications.
Autorzy:: Wright S; Saint Mary's Regional Medical Center, Reno, NV 89503, USA.; Western Surgical Group, Reno, NV 89502, USA.
Burkholz SR; Flow Pharma Inc., Warrensville Heights, OH 44128, USA.
Zelinsky C; Saint Mary's Regional Medical Center, Reno, NV 89503, USA.
Wittman C; Saint Mary's Regional Medical Center, Reno, NV 89503, USA.
Carback RT; Flow Pharma Inc., Warrensville Heights, OH 44128, USA.
Harris PE; Flow Pharma Inc., Warrensville Heights, OH 44128, USA.
Blankenberg T; Flow Pharma Inc., Warrensville Heights, OH 44128, USA.; Shasta Pathology Associates, Redding, CA 96001, USA.
Herst CV; Flow Pharma Inc., Warrensville Heights, OH 44128, USA.
Rubsamen RM; Saint Mary's Regional Medical Center, Reno, NV 89503, USA.; Flow Pharma Inc., Warrensville Heights, OH 44128, USA.; Cleveland Medical Center, University Hospitals, Cleveland, OH 44106, USA.; Case Western Reserve School of Medicine, Cleveland, OH 44106, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 23; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 23.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/genetics
Breast Neoplasms*/therapy
Breast Neoplasms*/metabolism
Carcinoma, Intraductal, Noninfiltrating*/metabolism
Carcinoma, Ductal, Breast*/pathology
Female ; Humans ; Survivin/genetics ; Inhibitor of Apoptosis Proteins/genetics ; Inhibitor of Apoptosis Proteins/metabolism ; Breast/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Classifying invasive lobular carcinoma as special type breast cancer may be reducing its treatment success: A comparison of survival among invasive lobular carcinoma, invasive ductal carcinoma, and no-lobular special type breast cancer.
Autorzy:: Cosar R; Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Sut N; Department of Biostatistics, Faculty of Medicine, Trakya University, Edirne, Turkey.
Topaloglu S; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Tastekin E; Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Nurlu D; Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Ozler T; Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Şenödeyici E; Faculty of Medicine, Trakya University, Edirne, Turkey.
Dedeli M; Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Chousein M; Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Cicin I; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Jul 10; Vol. 18 (7), pp. e0283445. Date of Electronic Publication: 2023 Jul 10 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Carcinoma, Lobular*/therapy
Carcinoma, Lobular*/pathology
Breast Neoplasms, Male*/surgery
Carcinoma, Ductal*
Carcinoma, Ductal, Breast*/pathology
Humans ; Female ; Male ; Mastectomy ; Treatment Outcome ; Prognosis ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: A risk stratification model to predict chemotherapy benefit in medullary carcinoma of the breast: a population-based SEER database.
Autorzy:: Chen H; Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China.
Pu S; Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China.
Wang L; Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China.
Zhang H; Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China.
Yan Y; Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China.
He J; Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China. .
Zhang J; Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Jul 03; Vol. 13 (1), pp. 10704. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Medullary*
Carcinoma, Neuroendocrine*
Carcinoma, Ductal, Breast*
Breast Neoplasms*/drug therapy
Humans ; Female ; Nomograms ; Risk Assessment ; SEER Program
SCR Disease Name:: Thyroid cancer, medullary

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Does Diffusely Infiltrating Lobular Carcinoma of the Breast Arise from Epithelial-Mesenchymal Hybrid Cells?
Autorzy:: Tabár L; Falun Central Hospital, Lasarettsvägen 10, 791 82 Falun, Sweden.
Bozó R; Department of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, Korányi Street 6, H-6720 Szeged, Hungary.
Dean PB; Department of Diagnostic Radiology, Faculty of Medicine, University of Turku, FI-20014 Turun, Finland.
Ormándi K; Department of Radiology, University of Szeged, Semmelweis Street 6, H-6725 Szeged, Hungary.
Puchkova O; Department of Breast Imaging, Il'inskaya Hospital, Novorizhskoye Highway 9 km, 101000 Moscow, Russia.
Oláh-Németh O; Department of Pathology, University of Szeged, Állomás Street 2, H-6725 Szeged, Hungary.
Németh IB; Department of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, Korányi Street 6, H-6720 Szeged, Hungary.
Veréb Z; Department of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, Korányi Street 6, H-6720 Szeged, Hungary.
Yen MF; School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Wuxing Street, Taipei 110, Taiwan.
Chen LS; School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Wuxing Street, Taipei 110, Taiwan.
Chen HH; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, 17 Hsuchow Road, Taipei 100, Taiwan.
Vörös A; Department of Pathology, University of Szeged, Állomás Street 2, H-6725 Szeged, Hungary.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jun 28; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 28.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Lobular*/metabolism
Breast Neoplasms*/metabolism
Mammary Glands, Human*/metabolism
Carcinoma, Ductal, Breast*/pathology
Humans ; Female ; Breast/metabolism ; Epithelial Cells/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Carcinoma, Ductal, Breast"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język